37

Spineway SAMUN Spineway Stock Report

Last reporting period 31 Dec, 2023

Updated —

Last price

Market cap $B

0

Micro

Exchange

XMUN - Boerse Muenchen

37S0.MU Stock Analysis

37

Uncovered

Spineway SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-39/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

3.642 B

Spineway SA is engaged in the design, production, and sale of spinal column implants and surgical instruments. The company is headquartered in Ecully, Auvergne-Rhone-Alpes. The company went IPO on 2013-02-08. The company designs, produces and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, among others.

View Section: Eyestock Rating